OLAWUNMI OYERINDE: Open Payments
NPI 1275783557 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 71 payments from 8 companies in 2025. Trend: 2023 $338 · 2024 $179 · 2025 $1,617
Food & beverage: $1,617
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 43 | $950 |
| Gilead Sciences, Inc. | 15 | $359 |
| Merck Sharp & Dohme LLC | 6 | $155 |
| Theratechnologies Inc. | 2 | $62 |
| Indivior Inc. | 2 | $35 |
| Novo Nordisk Inc | 1 | $27 |
| EMD Serono, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
Products named: CABENUVA, DOVATO, APRETUDE, Biktarvy, PIFELTRO, EGRIFTA, RUKOBIA, SUBLOCADE.
Industry payments across TX — which companies pay providers there.
